Report
Novartis : Towards a good H2 and beyond….
>Feedback from conference call after Q2 results: warmly received publication - Novartis closed yesterday evening up +3.2% - A strong increase given earnings just a shade ahead of those forecast by the consensus (around 1.5% higher for sales and operating profit). Excl. Sandoz (-2%cc), still penalised by pressure on prices for US generics, the market welcomed growth for the pharma division (+8%cc), also new products (Cosentyx and Entresto) and Glivec, which showed good...
Underlying
NOVARTIS N 2. LINIE
Provider
Oddo BHF
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Oussema Denguir
Other Reports on these Companies
Other Reports from Oddo BHF
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.